image
1066
image Language

Overview

The Department of Oncology at Apollo Hospitals, Gurugram, provides assessment and treatment for adults and children with suspected or confirmed cancer, as well as selected blood disorders. Care may involve medical oncology, cancer surgery, radiation oncology, hematology, pediatric oncology, imaging, pathology and supportive care.

Cancer care is planned around the type of cancer, its stage, test results, the person's general health and their priorities. Treatment may include surgery, medicines, radiation therapy, stem cell transplantation or a combination of approaches. Some people also need pain and symptom control, nutrition support, rehabilitation, psychological care or help with the effects of treatment.

Selected or complex cases may be reviewed by specialists from different disciplines so that the diagnosis and treatment options can be considered together. Not every patient needs every test or treatment, and recommendations may change as new information becomes available.

Our Oncology Team

The oncology team may include medical, surgical and radiation oncologists, hematologists, pediatric oncologists, pathologists, radiologists, nuclear medicine physicians, interventional radiologists, oncology nurses, pharmacists, dietitians, rehabilitation professionals, pain specialists and palliative care clinicians. Organ-specific specialists may join the care team when needed. Our specialists include:

Oncology
Gynecologic Oncology
35+ years , MBBS, MD Obstetrics & Gynaecology
Oncology
Gynecologic Oncology
18+ years , MBBS, Diploma in Obstetrics & Gynaecology, DNB Obstetrics & Gynaecology
Urology
Oncology
16+ years , MBBS, M.S. MAMC New Delhi, M.Ch Urology (AIIMS, New Delhi), FRCS UROLOGY ENGLAND, Fellowship Renal Oncology and Robotic Surgery Oxford University UK, Academic Visitor University of Oxford UK
Pediatric Hematology-Oncology
10+ years , MBBS, MD (Pediatrics), IAP Fellowship (Pediatric Hematology and Oncology)

Sub-specialities

Medical Oncology

Treatment of cancer with medicines such as chemotherapy, targeted therapy, immunotherapy and hormonal therapy. The choice and sequence of treatment depend on the cancer type, stage, biomarkers, previous treatment and the patient's health.

Surgical Oncology

Cancer surgery for suitable patients, including operations to remove a tumor, assess lymph nodes, relieve symptoms or reconstruct an affected area. Minimally invasive or organ-preserving techniques may be considered when they are clinically appropriate.

Radiation Oncology

Use of carefully planned radiation to treat cancer, reduce the risk of recurrence or relieve symptoms. Techniques and schedules vary with the treatment goal and the area being treated.

Hematology and Hemato-oncology

Diagnosis and treatment of leukemia, lymphoma, myeloma, myelodysplastic syndromes and selected noncancerous blood disorders. Care may include blood and bone marrow tests, systemic treatment, transfusion support and infection prevention.

Stem Cell Transplantation

Assessment and transplantation for selected blood cancers, bone marrow disorders and other defined conditions, using the patient's own cells or donor cells when appropriate.

Pediatric Oncology and Hematology

Age-appropriate care for children and adolescents with cancers and blood disorders, coordinated with pediatric intensive care, infection management, nutrition, rehabilitation and psychosocial support when required.

Gynecologic Oncology

Care for cancers of the cervix, uterus, ovaries, fallopian tubes, vagina and vulva, with surgery, systemic treatment and radiation considered according to the diagnosis and stage.

Breast Oncology

Assessment and treatment of breast cancer through coordinated imaging, pathology, surgery, systemic treatment, radiation and rehabilitation. Breast-conserving treatment may be an option for selected patients.

Head and Neck Oncology

Treatment of cancers of the mouth, throat, voice box, salivary glands, thyroid and related areas, with attention to speech, swallowing, nutrition and rehabilitation.

Thoracic Oncology

Care for cancers involving the lungs, pleura, mediastinum and chest wall, planned with input from pulmonology, thoracic surgery, radiology, pathology and radiation or medical oncology.

Gastrointestinal and Hepatobiliary Oncology

Treatment of cancers of the esophagus, stomach, bowel, anus, liver, gallbladder, bile ducts and pancreas through coordinated medical, surgical, endoscopic and radiation care.

Uro-Oncology

Care for cancers of the kidney, bladder, prostate, testis, penis and adrenal gland, including surgical and nonsurgical treatment. 

Neuro-oncology

Multidisciplinary care for tumors of the brain, spine and nervous system, with neurosurgery, radiation oncology, medical oncology, pathology and rehabilitation involved as needed.

Musculoskeletal Oncology

Assessment and treatment of primary bone and soft-tissue tumors, with limb-preserving surgery considered in selected cases. 

Nuclear Medicine and Molecular Imaging

PET-CT and other nuclear medicine studies may support diagnosis, staging, response assessment or treatment planning. Certain cancers may also be treated with radiopharmaceuticals.

Oncopathology and Molecular Diagnostics

Examination of tissue, blood or bone marrow helps establish and classify a diagnosis. Immunohistochemistry, cytogenetic or molecular tests may be used when they can clarify prognosis or guide treatment.

Palliative, Supportive and Survivorship Care

Management of pain, nausea, fatigue, breathlessness, nutrition problems, emotional distress and other concerns during or after treatment. Palliative care can be provided alongside cancer-directed treatment.

Conditions We Treat

  • Breast Cancer
  • Head, Neck and Thyroid Cancers
  • Thoracic Cancers
  • Digestive System Cancers
  • Gynecologic Cancers
  • Genitourinary Cancers
  • Blood Cancers and Blood Disorders
  • Cancers in Children
  • Other Cancers
Breast Cancer
Breast Cancer
  • Breast cancer: A new breast lump, skin or nipple change, nipple discharge or a lump in the armpit should be assessed. Many breast changes are benign, but examination and imaging help determine whether a biopsy is needed.
  • Recurrent or metastatic breast cancer: Cancer that returns or spreads may be managed with systemic treatment, radiation, selected procedures and symptom control. Treatment is guided by previous therapy, disease location and tumor biomarkers.
Head, Neck and Thyroid Cancers new
Head, Neck and Thyroid Cancers
  • Oral and throat cancers: A persistent mouth ulcer, unexplained lump, pain or difficulty swallowing, voice change or neck swelling needs evaluation. Tobacco and areca nut use are important preventable risk factors.
  • Laryngeal and salivary gland cancers: Persistent hoarseness, swallowing difficulty, a neck mass or swelling near the jaw may require endoscopy, imaging and biopsy.
  • Thyroid cancer: A thyroid nodule is usually not cancer, but selected nodules need ultrasound assessment and needle sampling. Treatment depends on the cancer type, extent and individual risk.
Thoracic Cancers
Thoracic Cancers
  • Lung cancer: Persistent cough, coughing blood, chest pain, unexplained weight loss or breathlessness should be assessed, particularly in people with a smoking or exposure history. Molecular and immune-marker testing is important for many advanced non-small cell lung cancers.
  • Pleural and mediastinal tumors: Tumors involving the lining of the lung or central chest may need imaging, tissue diagnosis and coordinated surgical, medical or radiation treatment.
Digestive System Cancers new
Digestive System Cancers
  • Esophageal and stomach cancers: Progressive swallowing difficulty, persistent upper abdominal discomfort, vomiting, anemia, bleeding or unexplained weight loss may prompt endoscopy and biopsy.
  • Colorectal and anal cancers: A lasting change in bowel habits, rectal bleeding, abdominal pain or iron-deficiency anemia needs assessment. Screening and the removal of precancerous adenomatous polyps can lower colorectal cancer risk.
  • Liver, gallbladder, bile duct and pancreatic cancers: Jaundice, dark urine, persistent upper abdominal or back pain, appetite loss or unexplained weight loss may require blood tests and imaging.
Gynecologic Cancers
Gynecologic Cancers
  • Cervical cancer: Bleeding after sex, between periods or after menopause, persistent discharge or pelvic pain should be evaluated. HPV vaccination and appropriate screening reduce risk.
  • Endometrial cancer: Bleeding after menopause is the most common warning sign. It does not always mean cancer, but every episode needs assessment.
  • Ovarian and fallopian tube cancers: New, persistent bloating, early fullness, abdominal or pelvic discomfort and urinary symptoms may need evaluation, especially when they occur frequently.
Genitourinary Cancers
Genitourinary Cancers
  • Prostate cancer: Early disease often causes no symptoms. Urinary symptoms are commonly caused by noncancerous conditions, and the decision to test with PSA should follow an informed discussion of benefits and limitations.
  • Kidney and bladder cancers: Blood in the urine needs assessment even when painless or seen only once. Imaging, urine tests and cystoscopy may be used to identify the cause.
  • Testicular and penile cancers: A painless testicular lump, change in size or heaviness needs prompt assessment. A persistent penile sore, lump or skin change should also be examined.
Blood Cancers and Blood Disorders
Blood Cancers and Blood Disorders
  • Leukemia: Abnormal blood-forming cells can cause fatigue, infections, fever, bruising, bleeding or bone pain. Diagnosis may require blood tests, bone marrow examination, flow cytometry and genetic testing.
  • Lymphoma: Painless swollen lymph nodes, drenching night sweats, unexplained fever, itching or weight loss may need assessment. A tissue biopsy is often required to identify the lymphoma subtype.
  • Multiple myeloma: This plasma-cell cancer may cause bone pain, anemia, kidney problems, recurrent infections or high calcium. Blood, urine, bone marrow and imaging tests help establish the diagnosis.
  • Myelodysplastic and myeloproliferative disorders: These conditions affect blood-cell production and may cause low or high blood counts, clotting, bleeding or enlargement of the spleen. Treatment varies widely by subtype and risk.
  • Selected noncancerous blood disorders: Hematology care may also include assessment of anemia, low platelets, clotting disorders, hemoglobin disorders and bone marrow failure.
Cancers in Children new
Cancers in Children

Childhood cancers: Leukemias, lymphomas, brain tumors, neuroblastoma, Wilms tumor, bone tumors and soft-tissue sarcomas are among the cancers seen in younger patients. Persistent unexplained fever, pallor, bruising, swelling, bone pain, headaches or changes in balance or vision should be evaluated. These symptoms often have noncancerous causes.

Other Cancers
Other Cancers
  • Brain and spinal tumors: Symptoms vary with location and may include new seizures, persistent or worsening headaches, weakness, sensory changes, balance problems or changes in behavior or vision.
  • Bone and soft-tissue sarcomas: A growing lump, persistent deep pain or unexplained swelling requires assessment. Biopsy should be planned by the team that will manage the tumor because the route can affect later surgery.
  • Skin cancers: A changing mole, a sore that does not heal or a new skin growth should be examined. Any suspicious lesion may need dermoscopic assessment or biopsy.
  • Cancer of unknown primary: Sometimes cancer is found after it has spread but the site where it began is not immediately clear. Pathology, imaging and selected molecular tests help guide further investigation and treatment.

Diagnostics & Investigations

Clinical assessment

The consultation reviews symptoms, previous illnesses, medicines, family history, tobacco and alcohol exposure, earlier reports and the person's general health. Examination is directed by the clinical concern.

Biopsy and tissue sampling

A needle, endoscope or operation may be used to obtain tissue. The method and biopsy route are selected for the suspected tumor and its location. Histopathology is usually needed to confirm and classify solid tumors, while some blood cancers are diagnosed through blood and bone marrow testing.

Histopathology and immunohistochemistry

A pathologist examines cells and tissue to identify the tumor type, grade and selected markers. Additional stains or tests may be required, and results sometimes take longer when a case is complex or tissue needs referral.

Molecular, genomic and biomarker testing

Selected cancers are tested for changes that may help estimate prognosis or identify treatment options. Not every cancer needs broad genomic testing, and a detected change does not always have an effective treatment.

Blood and bone marrow tests

A complete blood count, blood film, chemistry tests, flow cytometry, bone marrow aspiration or biopsy, cytogenetics and molecular tests may be used for suspected blood cancers or marrow disorders.

CT, MRI and ultrasound

Imaging helps locate a tumor, assess its relationship to nearby structures, look for spread and plan treatment. The modality and use of contrast depend on the clinical question and kidney function, allergies, pregnancy status and other factors.

PET-CT and nuclear medicine imaging

These studies use a small amount of radioactive tracer to assess metabolic activity or organ function. Preparation, scan duration and usefulness vary by tracer and cancer type.

Mammography and breast ultrasound

Mammography is central to breast screening and assessment in appropriate age groups. Ultrasound may further assess a lump or an area seen on mammography and is often used to guide a biopsy.

Endoscopy

Gastroscopy, colonoscopy, bronchoscopy, cystoscopy or other endoscopic procedures allow direct examination and tissue sampling. Sedation or anesthesia may be used according to the procedure and patient.

Sentinel lymph node biopsy

In selected cancers, the first draining lymph node or nodes are identified and examined to help assess spread. The result is considered with other clinical findings when planning further treatment.

Tumor markers

Blood markers can support diagnosis, treatment monitoring or follow-up in defined situations. Most are not sufficiently accurate to diagnose or screen for cancer on their own.

Organ-function and fitness assessment

Heart, lung, kidney and liver tests, infection screening, nutrition assessment and anesthesia review may be needed before surgery, systemic treatment, radiation or transplantation.

Cancer screening

Screening aims to find selected cancers or precancerous changes before symptoms develop. In India, population-level programs include oral, breast and cervical cancer screening. Other screening decisions should be based on personal risk and current guidance. Screening is not a substitute for evaluating symptoms.

Procedures & Treatments

  • Cancer surgery
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Hormonal therapy
  • External beam radiation therapy
  • Stereotactic radiation therapy
  • Brachytherapy
  • Radiopharmaceutical therapy
  • Stem cell transplantation
  • Transfusion and hematology support
  • Palliative care
  • Fertility preservation
  • Psycho-oncology and social support
  • Rehabilitation
  • Nutrition support
  • Survivorship and follow-up
Cancer surgery

Surgery may remove a tumor, assess its extent, relieve an obstruction or other symptom, or support reconstruction. The operation and margin or lymph-node approach differ by cancer type. Minimally invasive, robotic or organ-preserving surgery may be considered for suitable patients.

Cancer surgery
Chemotherapy

Medicines that kill or slow rapidly dividing cells may be given by mouth, injection or infusion. Side effects differ by drug and can often be prevented or managed, but urgent review is needed for fever or signs of infection during treatment.

Chemotherapy
Targeted therapy

These medicines act on specific proteins or changes that help some cancers grow. Treatment usually requires an appropriate target or clinical indication. Side effects differ from those of chemotherapy but can still be serious and need monitoring.

Targeted therapy
Immunotherapy

Immunotherapy helps the immune system recognize or attack certain cancers. Suitability depends on the cancer, approved indication, biomarkers in some cases, previous treatment and overall health. Immune-related side effects can affect almost any organ and should be reported promptly.

Immunotherapy
Hormonal therapy

Treatment that blocks or lowers hormones may be used for hormone-sensitive breast, prostate, endometrial and other cancers. Side effects and duration depend on the medicine and treatment goal.

Hormonal therapy
External beam radiation therapy

Radiation is delivered from a machine outside the body. Planning uses imaging to shape the treatment around the target while limiting exposure to nearby tissues. Treatment may be given in one, a few or many sessions. A person is not radioactive after external beam treatment.

External beam radiation therapy
Stereotactic radiation therapy

Highly focused radiation may be used for selected small tumors or limited areas of spread in the brain, lung, spine, liver or other locations. Suitability depends on size, location and nearby sensitive structures. 

Stereotactic radiation therapy
Brachytherapy

A radiation source is placed inside or close to the treatment area for selected cancers, including some gynecologic and prostate cancers. Temporary or permanent sources and safety precautions vary by procedure. 

Brachytherapy
Radiopharmaceutical therapy

Radioactive medicines that travel to a specific target may treat selected thyroid, prostate or neuroendocrine cancers. Eligibility, isolation needs and post-treatment precautions depend on the medicine.

Radiopharmaceutical therapy
Stem cell transplantation

High-dose treatment followed by infusion of blood-forming stem cells may be used for selected leukemias, lymphomas, myeloma and marrow disorders. It requires detailed eligibility assessment, donor matching when relevant and close infection monitoring.

Stem cell transplantation
Transfusion and hematology support

Red-cell, platelet or plasma transfusion and treatment of clotting or bleeding problems may be required during cancer care. Blood products are used according to clinical need and testing protocols.

Transfusion and hematology support
Palliative care

Palliative care focuses on comfort, function and quality of life at any stage of serious illness. It can be provided alongside treatment intended to control or cure cancer and also supports families and caregivers.

Palliative care
Fertility preservation

Cancer and some treatments can affect fertility. When medically feasible, options such as sperm, egg, embryo or tissue preservation should be discussed before treatment begins. Urgent treatment may limit the time or options available. 

Fertility preservation
Psycho-oncology and social support

Counseling can help patients and families cope with uncertainty, changes in body image, treatment stress, sleep problems, anxiety, low mood and practical concerns. 

Psycho-oncology and social support
Rehabilitation

Physiotherapy, occupational therapy, speech and swallowing therapy, lymphedema care and exercise guidance may help maintain or restore function during and after treatment.

Rehabilitation
Nutrition support

A dietitian can help with reduced appetite, weight loss, swallowing difficulty, altered taste, bowel symptoms and nutrition during treatment. Restrictive diets or supplements should not replace prescribed cancer treatment.

Nutrition support
Survivorship and follow-up

Follow-up may monitor for recurrence, late effects, new health problems and emotional or functional concerns. The schedule and tests depend on the cancer, treatment and time since therapy.

Survivorship and follow-up

Technology & Advancements

  • Molecular profiling
  • Modern radiation planning and delivery
  • Stereotactic radiosurgery and radiotherapy
  • PET-CT and nuclear medicine
  • Minimally invasive and robotic surgery
  • Interventional oncology
  • Infusion and day-care systems
  • Stem cell transplant environment
  • Digital pathology and multidisciplinary review
Molecular profiling new
Molecular profiling

Biomarker, genetic and genomic tests can refine diagnosis or help identify treatment options for selected cancers. Results must be interpreted in the clinical context.

Modern radiation planning and delivery new
Modern radiation planning and delivery

Three-dimensional planning, intensity-modulated radiation therapy, image guidance and motion-management techniques can help shape treatment around the target. The technique is selected according to the cancer and treatment goal. 

Stereotactic radiosurgery and radiotherapy
Stereotactic radiosurgery and radiotherapy

SRS and SBRT can deliver focused treatment in selected cases while limiting the number of sessions. These techniques are not suitable for every tumor.

PET-CT and nuclear medicine
PET-CT and nuclear medicine

Molecular imaging can support staging, treatment response assessment and planning for selected cancers. Some tracers can also pair diagnosis with targeted radionuclide treatment. 

Minimally invasive and robotic surgery new
Minimally invasive and robotic surgery

Laparoscopic, thoracoscopic and robotic platforms may support smaller-incision surgery for suitable tumors. The surgeon recommends the approach that offers the most appropriate cancer control and safety. 

Interventional oncology new
Interventional oncology

Image-guided biopsy, drainage, tumor ablation and embolization may support diagnosis, local treatment or symptom relief in selected patients. 

Infusion and day-care systems new
Infusion and day-care systems

Protocol-based medicine preparation, identity checks, infusion monitoring and emergency response processes support safer systemic treatment. 

Stem cell transplant environment new
Stem cell transplant environment

Transplant care requires controlled rooms, blood-bank support, infection surveillance and an experienced multidisciplinary team. 

Digital pathology and multidisciplinary review new
Digital pathology and multidisciplinary review

Digital image sharing and structured case review can help specialists examine pathology, imaging and treatment options together.

Why Choose Apollo Hospitals for Oncology in Gurugram

Multidisciplinary planning

Selected or complex cases may be discussed by medical, surgical and radiation oncologists with pathologists, radiologists and organ-specific specialists.

Care across cancer types

 The service may cover common solid tumors, blood cancers, pediatric cancers and selected rare tumors through disease-focused teams.

Integrated diagnostics

Imaging, pathology, endoscopy, nuclear medicine and molecular testing can be coordinated to support diagnosis and staging.

Medical, surgical and radiation treatment

Access to different treatment disciplines supports individualized sequencing rather than a single standard approach. 

Hematology and transplant support

Specialized care may be available for blood cancers and patients who need stem cell transplantation. 

Pediatric cancer care

Children and adolescents may receive age-appropriate oncology and hematology care with pediatric and psychosocial support. 

Support throughout treatment

Oncology nursing, pain and palliative care, nutrition, rehabilitation and psychological support may be incorporated according to need.

Urgent-care pathways

Fever during chemotherapy, severe treatment reactions and complications such as bleeding or obstruction need rapid assessment.

Follow-up and survivorship

Monitoring after treatment can address recurrence risk, late effects, rehabilitation and long-term health needs.

Frequently Asked Questions

1 Which symptoms could be a warning sign of cancer?
icon icon

A new or growing lump, unexplained bleeding, a persistent cough or hoarseness, a non-healing mouth or skin lesion, a lasting change in bowel or bladder habits, difficulty swallowing, unexplained weight loss or unusual fatigue should be assessed. These symptoms often have noncancerous causes, but persistence or progression matters.

2 Can a biopsy cause cancer to spread?
icon icon

Tumor seeding along a biopsy tract is very rare for most routine biopsies. The care team selects the biopsy method and route according to the suspected tumor because planning is especially important for certain cancers. The diagnostic benefit usually outweighs this small risk when a biopsy is clinically indicated.

3 How long does it take to diagnose and stage cancer?
icon icon

Timing varies with the biopsy type, pathology complexity, need for additional stains or molecular tests and the imaging required. The team should explain which results are pending and whether treatment must wait for all of them.

4 Can cancer be cured?
icon icon

Some cancers can be cured, particularly when found at an earlier stage, while others can be controlled for long periods. Outcomes depend on the cancer type, stage, biology, response to treatment and the person's health. No responsible team can promise a cure before evaluating the individual case.

5 Is cancer contagious or always inherited?
icon icon

Cancer is not contagious. Most cancers are not caused by a single inherited change, although some families carry genetic variants that increase risk. Genetic counseling may be helpful when cancer occurs unusually young, affects several relatives or has a pattern linked to an inherited syndrome.

6 Does everyone with cancer need chemotherapy?
icon icon

No. Treatment may involve surgery, radiation, hormonal therapy, targeted therapy, immunotherapy, observation or supportive care, with or without chemotherapy. The recommendation depends on the diagnosis and treatment goal.

7 Will chemotherapy always cause hair loss?
icon icon

No. Hair loss depends on the medicine, dose and schedule. Some treatments cause complete hair loss, some cause thinning and others have little effect on hair. Hair usually grows back after treatment, although texture or color can temporarily change.

8 Does radiation therapy make a person radioactive?
icon icon

External beam radiation does not make a person radioactive. Some internal radiation and radiopharmaceutical treatments can require temporary precautions around other people. The nuclear medicine or radiation team provides specific instructions.

9 Can I continue working during cancer treatment?
icon icon

Many people work through at least part of treatment, while others need reduced hours or leave. The answer depends on the treatment, symptoms, infection risk, type of work and travel demands. Discuss practical adjustments with the care team and employer.

10 Does sugar feed cancer?
icon icon

All cells use glucose for energy. Eliminating sugar has not been shown to cure or control cancer, and highly restrictive diets can cause harmful weight or muscle loss. A balanced diet tailored to symptoms and treatment needs is usually more useful.

11 Are herbal remedies or supplements safe during treatment?
icon icon

Not always. Some can change how cancer medicines work, increase bleeding, affect the liver or kidneys, or contain undeclared ingredients. Tell the oncology team about every supplement or traditional remedy before using it. They should not replace evidence-based treatment.

12 Can I seek a second opinion?
icon icon

Yes. A second opinion can confirm the diagnosis, clarify options or help with a major decision. Bring pathology reports and slides or blocks when requested, imaging, laboratory results, treatment records and a current medicine list.

13 Does palliative care mean treatment has stopped?
icon icon

No. Palliative care focuses on pain, symptoms, emotional well-being and quality of life. It can begin at diagnosis and be provided alongside surgery, chemotherapy, radiation or other cancer treatment.

14 Can cancer treatment affect fertility?
icon icon

Yes. Some surgery, chemotherapy, radiation and hormonal treatments can reduce fertility temporarily or permanently. When time and medical circumstances allow, fertility preservation should be discussed before treatment begins.

15 What happens after cancer treatment ends?
icon icon

The team creates a follow-up plan based on the cancer and treatment. Visits may address recurrence monitoring, late effects, medicines, vaccination, rehabilitation, emotional health and age-appropriate screening. Report new or persistent symptoms rather than waiting for the next scheduled visit.

16 Can cancer be prevented?
icon icon

Not every cancer is preventable, but risk can be reduced. Avoid tobacco and areca nut, limit or avoid alcohol, stay physically active, maintain a healthy weight, receive recommended HPV and hepatitis B vaccines and take part in appropriate screening. Seek medical advice for persistent symptoms even if a screening test was normal.

View All
icon
×
image image image
Request a Callback
Request A Call Back
Request Type
Image
Doctor
Book Appointment
Appointments
View Book Appointment
Image
Hospitals
Find Hospital
Hospitals
View Find Hospital
Chat
Image
health-checkup
Book Health Checkup
Health Checks
View Book Health Checkup
Image
phone
Call Us
Call Us
View Call Us
Image
Doctor
Book Appointment
Appointments
View Book Appointment
Image
Hospitals
Find Hospital
Hospitals
View Find Hospital
Image
health-checkup
Book Health Checkup
Health Checks
View Book Health Checkup
Image
phone
Call Us
Call Us
View Call Us